Splice variants as novel targets in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Splice variants as novel targets in pancreatic ductal adenocarcinoma

Published:2017-06-07 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Wang Jun,Dumartin Laurent,Mafficini Andrea^ORCID,Ulug Pinar^ORCID,Sangaralingam Ajanthah,Alamiry Namaa Audi,Radon Tomasz P.,Salvia Roberto,Lawlor Rita T.,Lemoine Nicholas R.,Scarpa Aldo^ORCID,Chelala Claude,Crnogorac-Jurcevic Tatjana

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-03354-z.pdf

Reference50 articles.

1. Keren, H., Lev-Maor, G. & Ast, G. Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 11, 345–355 (2010).

2. Skotheim, R. I. & Nees, M. Alternative splicing in cancer: noise, functional, or systematic? Int J Biochem Cell Biol 39, 1432–1449 (2007).

3. Pan, Q., Shai, O., Lee, L. J., Frey, B. J. & Blencowe, B. J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40, 1413–1415 (2008).

4. Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008).

5. Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A. & Skotheim, R. I. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene 35, 2413–2427 (2016).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma;Cancer Gene Therapy;2024-09-04

2. Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer;Cell Biochemistry and Biophysics;2024-07-19

3. Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets;Molecular Oncology;2024-05-24

4. Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target;International Journal of Biological Sciences;2024

5. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing;Nature Communications;2023-12-19